The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sheep and Goat Pox Vaccines Market Research Report 2025
Synopsis
A single vaccine against sheep and goat pox (capripox) has been developed to protect sheep and goats throughout the capripox enzootic area.
The global Sheep and Goat Pox Vaccines market was valued at US$ 58 million in 2023 and is anticipated to reach US$ 72 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
The increasing incidence of Sheep and Goat Pox, a contagious viral disease affecting small ruminants, is driving the demand for vaccines. Factors such as the growing livestock industry, rising awareness about animal health, and government initiatives for disease control contribute to market expansion. Key players in the market are focusing on product development and strategic collaborations to gain a competitive advantage. Advancements in vaccine technology, such as the use of recombinant DNA techniques, are expected to fuel market growth. However, challenges such as regulatory hurdles and limited availability of vaccines in certain regions may impede market progress. Overall, the Sheep and Goat Pox vaccines market is projected to experience substantial growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Sheep and Goat Pox Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sheep and Goat Pox Vaccines.
Report Scope
The Sheep and Goat Pox Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sheep and Goat Pox Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sheep and Goat Pox Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agrovet
Biopharma
Dollvet
FGBI - Federal Centre for Animal Health
Hester Biosciences Limited
Indian Immunologicals Limited
Institut Pasteur d'Algerie
Intervac (PVT) Ltd.
JOVAC
Tiankang Biopharmacuetical
Vetal Company
Veterinary Research Institute
Segment by Type
Attenuated Live Vaccines
Killed Vaccines
Segment by Application
Sheep
Goat
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sheep and Goat Pox Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sheep and Goat Pox Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A single vaccine against sheep and goat pox (capripox) has been developed to protect sheep and goats throughout the capripox enzootic area.
The global Sheep and Goat Pox Vaccines market was valued at US$ 58 million in 2023 and is anticipated to reach US$ 72 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
The increasing incidence of Sheep and Goat Pox, a contagious viral disease affecting small ruminants, is driving the demand for vaccines. Factors such as the growing livestock industry, rising awareness about animal health, and government initiatives for disease control contribute to market expansion. Key players in the market are focusing on product development and strategic collaborations to gain a competitive advantage. Advancements in vaccine technology, such as the use of recombinant DNA techniques, are expected to fuel market growth. However, challenges such as regulatory hurdles and limited availability of vaccines in certain regions may impede market progress. Overall, the Sheep and Goat Pox vaccines market is projected to experience substantial growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Sheep and Goat Pox Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sheep and Goat Pox Vaccines.
Report Scope
The Sheep and Goat Pox Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sheep and Goat Pox Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sheep and Goat Pox Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agrovet
Biopharma
Dollvet
FGBI - Federal Centre for Animal Health
Hester Biosciences Limited
Indian Immunologicals Limited
Institut Pasteur d'Algerie
Intervac (PVT) Ltd.
JOVAC
Tiankang Biopharmacuetical
Vetal Company
Veterinary Research Institute
Segment by Type
Attenuated Live Vaccines
Killed Vaccines
Segment by Application
Sheep
Goat
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sheep and Goat Pox Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sheep and Goat Pox Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Sheep and Goat Pox Vaccines Market Overview
1.1 Product Overview and Scope of Sheep and Goat Pox Vaccines
1.2 Sheep and Goat Pox Vaccines Segment by Type
1.2.1 Global Sheep and Goat Pox Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Attenuated Live Vaccines
1.2.3 Killed Vaccines
1.3 Sheep and Goat Pox Vaccines Segment by Application
1.3.1 Global Sheep and Goat Pox Vaccines Market Value by Application: (2024-2030)
1.3.2 Sheep
1.3.3 Goat
1.4 Global Sheep and Goat Pox Vaccines Market Size Estimates and Forecasts
1.4.1 Global Sheep and Goat Pox Vaccines Revenue 2019-2030
1.4.2 Global Sheep and Goat Pox Vaccines Sales 2019-2030
1.4.3 Global Sheep and Goat Pox Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sheep and Goat Pox Vaccines Market Competition by Manufacturers
2.1 Global Sheep and Goat Pox Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sheep and Goat Pox Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sheep and Goat Pox Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Sheep and Goat Pox Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sheep and Goat Pox Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sheep and Goat Pox Vaccines, Product Type & Application
2.7 Sheep and Goat Pox Vaccines Market Competitive Situation and Trends
2.7.1 Sheep and Goat Pox Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sheep and Goat Pox Vaccines Players Market Share by Revenue
2.7.3 Global Sheep and Goat Pox Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sheep and Goat Pox Vaccines Retrospective Market Scenario by Region
3.1 Global Sheep and Goat Pox Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sheep and Goat Pox Vaccines Global Sheep and Goat Pox Vaccines Sales by Region: 2019-2030
3.2.1 Global Sheep and Goat Pox Vaccines Sales by Region: 2019-2024
3.2.2 Global Sheep and Goat Pox Vaccines Sales by Region: 2025-2030
3.3 Global Sheep and Goat Pox Vaccines Global Sheep and Goat Pox Vaccines Revenue by Region: 2019-2030
3.3.1 Global Sheep and Goat Pox Vaccines Revenue by Region: 2019-2024
3.3.2 Global Sheep and Goat Pox Vaccines Revenue by Region: 2025-2030
3.4 North America Sheep and Goat Pox Vaccines Market Facts & Figures by Country
3.4.1 North America Sheep and Goat Pox Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sheep and Goat Pox Vaccines Sales by Country (2019-2030)
3.4.3 North America Sheep and Goat Pox Vaccines Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Sheep and Goat Pox Vaccines Market Facts & Figures by Country
3.5.1 Europe Sheep and Goat Pox Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sheep and Goat Pox Vaccines Sales by Country (2019-2030)
3.5.3 Europe Sheep and Goat Pox Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sheep and Goat Pox Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Sheep and Goat Pox Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sheep and Goat Pox Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Sheep and Goat Pox Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Sheep and Goat Pox Vaccines Market Facts & Figures by Country
3.7.1 Latin America Sheep and Goat Pox Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sheep and Goat Pox Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Sheep and Goat Pox Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sheep and Goat Pox Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Sheep and Goat Pox Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sheep and Goat Pox Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sheep and Goat Pox Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sheep and Goat Pox Vaccines Sales by Type (2019-2030)
4.1.1 Global Sheep and Goat Pox Vaccines Sales by Type (2019-2024)
4.1.2 Global Sheep and Goat Pox Vaccines Sales by Type (2025-2030)
4.1.3 Global Sheep and Goat Pox Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Sheep and Goat Pox Vaccines Revenue by Type (2019-2030)
4.2.1 Global Sheep and Goat Pox Vaccines Revenue by Type (2019-2024)
4.2.2 Global Sheep and Goat Pox Vaccines Revenue by Type (2025-2030)
4.2.3 Global Sheep and Goat Pox Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Sheep and Goat Pox Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sheep and Goat Pox Vaccines Sales by Application (2019-2030)
5.1.1 Global Sheep and Goat Pox Vaccines Sales by Application (2019-2024)
5.1.2 Global Sheep and Goat Pox Vaccines Sales by Application (2025-2030)
5.1.3 Global Sheep and Goat Pox Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Sheep and Goat Pox Vaccines Revenue by Application (2019-2030)
5.2.1 Global Sheep and Goat Pox Vaccines Revenue by Application (2019-2024)
5.2.2 Global Sheep and Goat Pox Vaccines Revenue by Application (2025-2030)
5.2.3 Global Sheep and Goat Pox Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Sheep and Goat Pox Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Agrovet
6.1.1 Agrovet Corporation Information
6.1.2 Agrovet Description and Business Overview
6.1.3 Agrovet Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Agrovet Sheep and Goat Pox Vaccines Product Portfolio
6.1.5 Agrovet Recent Developments/Updates
6.2 Biopharma
6.2.1 Biopharma Corporation Information
6.2.2 Biopharma Description and Business Overview
6.2.3 Biopharma Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Biopharma Sheep and Goat Pox Vaccines Product Portfolio
6.2.5 Biopharma Recent Developments/Updates
6.3 Dollvet
6.3.1 Dollvet Corporation Information
6.3.2 Dollvet Description and Business Overview
6.3.3 Dollvet Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dollvet Sheep and Goat Pox Vaccines Product Portfolio
6.3.5 Dollvet Recent Developments/Updates
6.4 FGBI - Federal Centre for Animal Health
6.4.1 FGBI - Federal Centre for Animal Health Corporation Information
6.4.2 FGBI - Federal Centre for Animal Health Description and Business Overview
6.4.3 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Product Portfolio
6.4.5 FGBI - Federal Centre for Animal Health Recent Developments/Updates
6.5 Hester Biosciences Limited
6.5.1 Hester Biosciences Limited Corporation Information
6.5.2 Hester Biosciences Limited Description and Business Overview
6.5.3 Hester Biosciences Limited Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hester Biosciences Limited Sheep and Goat Pox Vaccines Product Portfolio
6.5.5 Hester Biosciences Limited Recent Developments/Updates
6.6 Indian Immunologicals Limited
6.6.1 Indian Immunologicals Limited Corporation Information
6.6.2 Indian Immunologicals Limited Description and Business Overview
6.6.3 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Product Portfolio
6.6.5 Indian Immunologicals Limited Recent Developments/Updates
6.7 Institut Pasteur d'Algerie
6.6.1 Institut Pasteur d'Algerie Corporation Information
6.6.2 Institut Pasteur d'Algerie Description and Business Overview
6.6.3 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Product Portfolio
6.7.5 Institut Pasteur d'Algerie Recent Developments/Updates
6.8 Intervac (PVT) Ltd.
6.8.1 Intervac (PVT) Ltd. Corporation Information
6.8.2 Intervac (PVT) Ltd. Description and Business Overview
6.8.3 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Product Portfolio
6.8.5 Intervac (PVT) Ltd. Recent Developments/Updates
6.9 JOVAC
6.9.1 JOVAC Corporation Information
6.9.2 JOVAC Description and Business Overview
6.9.3 JOVAC Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 JOVAC Sheep and Goat Pox Vaccines Product Portfolio
6.9.5 JOVAC Recent Developments/Updates
6.10 Tiankang Biopharmacuetical
6.10.1 Tiankang Biopharmacuetical Corporation Information
6.10.2 Tiankang Biopharmacuetical Description and Business Overview
6.10.3 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Product Portfolio
6.10.5 Tiankang Biopharmacuetical Recent Developments/Updates
6.11 Vetal Company
6.11.1 Vetal Company Corporation Information
6.11.2 Vetal Company Sheep and Goat Pox Vaccines Description and Business Overview
6.11.3 Vetal Company Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Vetal Company Sheep and Goat Pox Vaccines Product Portfolio
6.11.5 Vetal Company Recent Developments/Updates
6.12 Veterinary Research Institute
6.12.1 Veterinary Research Institute Corporation Information
6.12.2 Veterinary Research Institute Sheep and Goat Pox Vaccines Description and Business Overview
6.12.3 Veterinary Research Institute Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Veterinary Research Institute Sheep and Goat Pox Vaccines Product Portfolio
6.12.5 Veterinary Research Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sheep and Goat Pox Vaccines Industry Chain Analysis
7.2 Sheep and Goat Pox Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sheep and Goat Pox Vaccines Production Mode & Process
7.4 Sheep and Goat Pox Vaccines Sales and Marketing
7.4.1 Sheep and Goat Pox Vaccines Sales Channels
7.4.2 Sheep and Goat Pox Vaccines Distributors
7.5 Sheep and Goat Pox Vaccines Customers
8 Sheep and Goat Pox Vaccines Market Dynamics
8.1 Sheep and Goat Pox Vaccines Industry Trends
8.2 Sheep and Goat Pox Vaccines Market Drivers
8.3 Sheep and Goat Pox Vaccines Market Challenges
8.4 Sheep and Goat Pox Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
